Last deal

$700K

Amount

Grant

Stage

13.06.2024

Date

3

all rounds

$3.09M

Total amount

date founded

Financing round

General

About Company
Intuitive Biosciences provides tuberculosis and specific pathogen-free tests for non-human primate (NHP) research operations.

Industry

Sector :

Subsector :

founded date

01.01.2012

Number of employees

Company Type

For Profit

Last funding type

Grant

IPO status

Private

Description

Intuitive Biosciences is a company that specializes in providing tuberculosis and specific pathogen-free tests for non-human primate (NHP) research operations. Their tests are designed to make NHP research safer, more effective, and more efficient. The company's proprietary development platforms and world-class scientists allow them to continually expand their portfolio of diagnostics and research tools for the animal health and research markets. In addition to their tuberculosis and specific-pathogen-free tests, Intuitive Biosciences also offers a turnkey platform for multiplexed immunoassays, veterinary diagnostics for NHP infectious disease screening, and contract assay development services. Their easy-to-use platform screens NHP blood samples for infectious diseases including tuberculosis and SARS-CoV-2, making infectious disease screening fast and simple. Whether in your lab or theirs, Intuitive Biosciences can support your team and your research with their full immunoassay platform available as a turnkey system or OEM, including consumables, content, SilverQuant detection reagents, analysis instruments, and reporting software.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
Biogenex

Biogenex

BioGenex Labs designs and manufactures automated systems for cancer diagnosis and personalized medicine.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Fremont, CA, USA
Meso Scale Diagnostics

Meso Scale Diagnostics

Meso Scale Discovery (MSD) develops innovative assays and instruments for measuring molecules.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Rockville, MD, USA
Biosfer Teslab

Biosfer Teslab

Biosfer Teslab is a spin-off company that develops in-vitro diagnostic tests based on NMR technology.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

Reus, Tarragona, Spain
RareCyte

RareCyte

RareCyte is a life science research and diagnostic development company that isolates rare cells in the blood.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical Device

Location

Seattle, WA, USA

total rounds

6

total raised

$96M

Financials

Funding Rounds
5
3

Number of Funding Rounds

$3.09M

Money Raised

Their latest funding was raised on 13.06.2024. Their latest investor SBIR Advance. Their latest round Grant

Date 
Funding Round 
Investors 
Money Raised 
Lead 
13.06.2024
1
$700K
01.11.2019
1
04.06.2015
$1.33M
Co-Investors
Investors
2
0

Number of lead investors

2

Number of investors

Investor 
Lead 
Round 
Partners 
No
Grant
No
Venture - Series Unknown
SBIR Advance

SBIR Advance

SBIR Advance provides funding and resources to Wisconsin businesses for technology commercialization.

Sector

General Industrials

Subsector

Diversified Industrials

count Of Investments

18
Silicon Pastures

Silicon Pastures

Silicon Pastures is a Milwaukee-based venture capital firm founded in 2000.

Sector

Investment Banking and Brokerage Services

Subsector

Investment Services

Location

Milwaukee, WI, USA

count Of Investments

32

count Of Exists

4

People

Employee Profiles
6
Kimberly Luke

Kimberly Luke

Director Of Research and Development

Bill Patterson

Bill Patterson

Director of Research and Product Development

John Bart

John Bart

Director of Manufacturing

Shawn Guse

Shawn Guse

CEO

Activity

Recent News
1